Bristol-Myers Squibb
BMY
#193
Rank
HK$921.19 B
Marketcap
HK$451.11
Share price
3.85%
Change (1 day)
25.78%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): HK$27.82

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is HK$27.92. In 2025 the company made an earnings per share (EPS) of HK$27.14 an increase over its 2024 EPS that were of -HK$34.66.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$27.822.52%
2025HK$27.14-178.28%
2024-HK$34.66-213.92%
2023HK$30.4330.2%
2022HK$23.37-6.04%
2021HK$24.87-179.29%
2020-HK$31.37-281.37%
2019HK$17.30-27.21%
2018HK$23.76
2016HK$20.94175.26%
2015HK$7.61-19.83%
2014HK$9.49-22.44%
2013HK$12.2334.48%
2012HK$9.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.52 145.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.06 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.27-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$16.13-42.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$221.36 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$113.56 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$20.07-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$73.33 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$27.90-0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$54.51 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK